secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2025-09-04T23:59:59+00:00
Accession:  0001641172-25-026448
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lixte appoints new CFO, two board members; relocates HQ to Boca Raton
---------------------------------------------------------------------

- Rene Bernards, Regina Brown, Bas van der Baan resigned from Board; CFO Robert Weingarten resigned; all departures amicable.
- Peter Stazzone named CFO ($150k annual salary + options for 50k shares); Geordan Pursglove named President (already CEO/Chairman).
- Lourdes Felix and Guy Primus join Board; Felix chairs Audit Committee; Primus on Audit and Compensation.
- Corporate headquarters moved to Boca Raton, Florida to reduce costs and improve efficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000164117225026448/0001641172-25-026448-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000164117225026448/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-026448

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer